Novel Combination Therapy in the Treatment of Relapsed and Refractory Aggressive B-Cell Lymphoma
Clinical trial NCT02436707 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02436707
- Sponsor
- Canadian Cancer Trials Group
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-10-27
- Primary completion
- 2026-12-31
- Enrollment
- 129
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.